Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Belen Garijo
Pharma
Merck KGaA tweaks 2025 forecast as geopolitical concerns mount
Citing tariff threats, Merck KGaA has lowered its sales guidance for its life science arm, which offers various services and materials for partners.
Fraiser Kansteiner
May 15, 2025 1:20pm
Despite solid pharma growth, Merck KGaA sees total sales decline
Mar 7, 2024 3:32pm
Merck KGaA's contract manufacturing arm logs sharp sales decline
Aug 3, 2023 10:35am
CEOs of BioNTech, Bayer, Merck KGaA visit China
Nov 4, 2022 4:20pm
Merck KGaA picks Garijo to replace Oschmann as CEO
Sep 28, 2020 12:16pm
